BHI News Section Archives - Page 200 of 1201

The U.S. Centers for Disease Control and Prevention (CDC) recently provided updated guidance stating that participants in the Novavax PREVENT-19 Phase 3…

admin

Love0

News

September 21, 2021

HemoShear Therapeutics (PRNewsfoto/HemoShear Therapeutics) | | johnsoncitypress.com

CHARLOTTESVILLE, Va., Sept. 21, 2021 /PRNewswire/ -- HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has earned a milestone…

admin

Love0

BioTalk with Rich Bendis Podcast

September 20, 2021

BioTalk: From the 7th Annual BioHealth Capital Region Forum – Dr. Anthony Fauci

Listen to the audio as Rich Bendis, President and CEO of BioHealth Innovation conducts a fireside chat with Dr. Anthony…

admin

Love0

News

September 20, 2021

BioTalk: From the 7th Annual BioHealth Capital Region Forum – Dr. Anthony Fauci

Listen to the audio as Rich Bendis, President and CEO of BioHealth Innovation conducts a fireside chat with Dr. Anthony…

admin

Love0

News

September 20, 2021

Viewpoint: Ready for an HQ2 redux? It’s time to come together for new regional tech collaboration.

Remember the frenzy in 2017 when over 200 cities and towns across the U.S. bid to house the second headquarters…

admin

Love0

News

September 20, 2021

Patient-Centric Approach to Clinical Trials Improves Outcomes for All Stakeholders

According to researchers at the MIT Sloan School of Management, the probability of FDA approval of an industry-sponsored drug entering…

admin

Love0

BHI News Section

George Mason University: Mason Researchers Use Scent Analysis For COVID Diagnostics | Fairfax City, VA Patch

Women Building Bio 2021 | VirginiaBio – 2

DC welcomes the Children’s National Research & Innovation Campus | WTOP

Novavax EVP: It’s up to policymakers to decide use of COVID-19 vaccine | Devex

Novavax Statement on Proof of COVID-19 Vaccine Requirements for PREVENT-19 Clinical Trial Participants in the U.S.

HemoShear Therapeutics (PRNewsfoto/HemoShear Therapeutics) | | johnsoncitypress.com

BioTalk: From the 7th Annual BioHealth Capital Region Forum – Dr. Anthony Fauci

BioTalk: From the 7th Annual BioHealth Capital Region Forum – Dr. Anthony Fauci

Viewpoint: Ready for an HQ2 redux? It’s time to come together for new regional tech collaboration.

Patient-Centric Approach to Clinical Trials Improves Outcomes for All Stakeholders

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search